People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| IVXpress, Inc. | — | Other Health Care | Series D+ | $164.0M | $1.8B | 2021 |
| Active Endpoints Inc | — | Other Technology | Series A | $5.0M | $138.7M | 2009 |
Mark Taber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Taber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Skok | 1 | 12 |
| Eugene Kuznetsov | 1 | 5 |
| Andrew Kim | 1 | 4 |
| Dave Schulte | 1 | 2 |
| William Seibels | 1 | 2 |
| Michael Fiore | 1 | 2 |
| Michael E. Fiore | 1 | 1 |
| James E. Lippert | 1 | 1 |
| James Lippert | 1 | 1 |
| Steven Parks | 1 | 1 |
| Bruce Crosby | 1 | 1 |
| Donald Peterson | 1 | 1 |
| ROBERT POTTER | 1 | 1 |
| Donald Ray Peterson | 1 | 1 |
| Julie Felss Masino | 1 | 1 |
| Douglas Ghertner | 1 | 1 |
| Marty Felsenthal | 1 | 1 |
| Andrew E. Kim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.